C. Cochrane

S. Levine, P. Behan, C. Carpenter, 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Pulmonary surfactant in allergic inflammation: new insights into the molecular mechanisms of surfactant function.

C. Cochrane, 2005, American journal of physiology. Lung cellular and molecular physiology.

POLYMORPHONUCLEAR LEUKOCYTES IN IMMUNOLOGIC REACTIONS : THE DESTRUCTION OF VASCULAR BASEMENT MEMBRANE IN VIVO AND IN VITRO

C. Cochrane, B. S. Aikin, 1966 .

PATHOGENIC FACTORS IN VASCULAR LESIONS OF EXPERIMENTAL SERUM SICKNESS

C. Cochrane, W. Kniker, 1965, The Journal of experimental medicine.

The presence of neutrophil elastase and evidence of oxidation activity in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome.

R. Spragg, C. Cochrane, A. Cohen, 2015, The American review of respiratory disease.

289 Kininogenase activity in bronchoalveolar lavage (BAL) fluids in asthma

D. Proud, B. Bohl, C. Cochrane, 1985 .

Cell and tissue damage through antigen-antibody complexes.

C. Cochrane, F. Dixon, 1969, California medicine.

STUDIES ON CIRCULATING IMMUNE COMPLEXES

C. Cochrane, D. Hawkins, 1968, Journal of Experimental Medicine.

BOUND COMPLEMENT AND IMMUNOLOGIC INJURY OF BLOOD VESSELS

P. Ward, C. Cochrane, 1965, The Journal of experimental medicine.

ACUTE IMMUNE COMPLEX DISEASE IN RABBITS

P. Henson, C. Cochrane, 1971, The Journal of experimental medicine.

Pulmonary penetration of alpha 1-proteinase inhibitor administered parenterally to dogs.

R. Spragg, R. M. Smith, K. Moser, 1987, The American review of respiratory disease.

Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia.

D. Strayer, B. Bohl, C. Cochrane, 1983, The Journal of clinical investigation.

Biological Oxidants: Generation and Injurious Consequences

M. Gimbrone, C. Cochrane, 1992 .

Characterization of a human cDNA that encodes a functional receptor for platelet activating factor.

E. Prossnitz, R. Ye, C. Cochrane, 1991, Biochemical and biophysical research communications.

Activation of Hageman factor by proteases released during antigen challenge of human lung.

L. Lichtenstein, A. Kaplan, C. Cochrane, 1981, Transactions of the Association of American Physicians.

Detection of active kallikrein in induced blister fluids of hereditary angioedema patients

C. Cochrane, J. Curd, L. Prograis, 1980, The Journal of experimental medicine.

Dissemination of contact activation in plasma by plasma kallikrein

C. Cochrane, S. Revak, 1980, The Journal of experimental medicine.

Urate crystal--dependent cleavage of Hageman factor in human plasma and synovial fluid.

J. Griffin, M. Ginsberg, C. Cochrane, 1980, The Journal of laboratory and clinical medicine.

ACTIVATION OF HAGEMAN FACTOR IN SOLID AND FLUID PHASES

K. Wuepper, C. Cochrane, S. Revak, 1973, The Journal of experimental medicine.

THE FIRST COMPONENT OF THE KININ-FORMING SYSTEM IN HUMAN AND RABBIT PLASMA

K. Wuepper, C. Cochrane, Charles G. Cochrane, 1971, The Journal of experimental medicine.

THE LOCALIZATION OF CIRCULATING IMMUNE COMPLEXES IN EXPERIMENTAL SERUM SICKNESS

C. Cochrane, W. Kniker, 1968, The Journal of experimental medicine.

STUDIES ON THE LOCALIZATION OF CIRCULATING ANTIGEN-ANTIBODY COMPLEXES AND OTHER MACROMOLECULES IN VESSELS

C. Cochrane, 1963, The Journal of experimental medicine.

STUDIES ON THE LOCALIZATION OF CIRCULATING ANTIGEN-ANTIBODY COMPLEXES AND OTHER MACROMOLECULES IN VESSELS

C. Cochrane, 1963, The Journal of experimental medicine.

Inhibition of human bronchial kallikrein in asthma.

D. Proud, C. Cochrane, B. Zuraw, 1989, The American review of respiratory disease.

Anaphylactic release of a prekallikrein activator from human lung in vitro.

L. Lichtenstein, A. Kaplan, C. Cochrane, 1983, The Journal of clinical investigation.

The biochemistry and pathophysiology of the contact system of plasma.

J. Griffin, C. Cochrane, Charles G. Cochrane, 1982, Advances in immunology.

Restitution of superoxide generation in autosomal cytochrome-negative chronic granulomatous disease (A22(0) CGD)-derived B lymphocyte cell lines by transfection with p22phax cDNA

P. Newburger, M. Dinauer, L. Quilliam, 1993, The Journal of experimental medicine.

Pathogenesis of serum sickness.

C. Cochrane, F. Dixon, W. Weigle, 1958, A.M.A. archives of pathology.

Immunological induction of increased vascular permeability. I. A rabbit passive cutaneous anaphylactic reaction requiring complement, platelets, and neutrophils.

P. Henson, C. Cochrane, 1969 .

Biochemical factors in pulmonary inflammatory disease.

C. Cochrane, S. Revak, I. Schraufstatter, 1983, Federation proceedings.

Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells.

J. Griffin, D. Loskutoff, T. Edgington, 1980, The Journal of clinical investigation.

Reduction of lung injury by human surfactant treatment in respiratory distress syndrome.

D. Strayer, C. Cochrane, L. Gluck, 1983, Chest.

THE EFFECT OF COMPLEMENT DEPLETION ON EXPERIMENTAL TISSUE INJURY *

P. Henson, C. Cochrane, 1975, Annals of the New York Academy of Sciences.

The role of complement in experimental disease models

C. Cochrane, 2005, Springer Seminars in Immunopathology.

Glomerular basement membrane damage in immunological glomerulonephritis.

C. Cochrane, D. Hawkins, 1968, Immunology.

Intracellular localization of N-formyl chemotactic receptor and Mg2+ dependent ATPase in human granulocytes.

A. Jesaitis, L. Sklar, C. Cochrane, 1982, Biochimica et biophysica acta.

Photoaffinity labeling of the N‐formyl peptide receptor of human polymorphonuclear leukocytes

K. Preissner, A. Jesaitis, L. Sklar, 1982, Journal of cellular biochemistry.

Evidence for N‐formyl chemotactic peptide‐stimulated GTPase activity in human neutrophil homogenates

A. Jesaitis, L. Sklar, P. Hyslop, 1984, FEBS letters.

The participation of complement in renal disease and allograft rejection as assessed by model animal systems.

N. Cooper, C. Cochrane, 1974, Transplantation proceedings.

Bronchopulmonary segmental lavage with Surfaxin (KL(4)-surfactant) for acute respiratory distress syndrome.

A. Anzueto, T. Wiswell, R. M. Smith, 1999, American journal of respiratory and critical care medicine.

Role of granulocytes in immune complex-induced tissue injuries

C. Cochrane, 1977, Inflammation.

Immune Complex Disease

C. Cochrane, 1977 .

The role of immune complexes and complement in tissue injury.

C. Cochrane, 1968, The Journal of allergy.

THE ROLE OF COMPLEMENT IN THE ATTRACTION OF POLYMORPHONUCLEAR LEUKOCYTES TO IMMUNE REACTANTS

H. Müller-Eberhard, P. Ward, C. Cochrane, 1968 .

The Arthus Reaction

C. Cochrane, 1965 .

Inflammatory cells in solid murine neoplasms. I. TUMOR disaggregation and identification of constituent inflammatory cells

S. Russell, C. Cochrane, W. Doe, 1976, International journal of cancer.

STUDIES ON CIRCULATING IMMUNE COMPLEXES

C. Cochrane, D. Hawkins, 1968, The Journal of experimental medicine.

Release of soluble fibronectin containing an extra type III domain (ED1) during acute pulmonary injury mediated by oxidants or leukocytes in vivo.

M. Ginsberg, C. Cochrane, M. Ginsberg, 1988, The American review of respiratory disease.

Experimental pulmonary inflammatory injury in the monkey.

R. Clancy, B. Bohl, I. Schraufstätter, 1985, The Journal of clinical investigation.

Hypoxanthine and Oxygen Induced Lung Injury: A Possible Basic Mechanism of Tissue Damage?

C. Cochrane, O. Saugstad, L. Gluck, 1984, Pediatric Research.

The Stimulation of Leukocytes In Vivo

R. Spragg, C. Cochrane, S. Revak, 1983 .

The quaternary structure of the plasma membrane b-type cytochrome of human granulocytes.

A. Jesaitis, R. Allen, C. Cochrane, 1988, Biochimica et biophysica acta.

THE DERIVATION OF TWO DISTINCT ANAPHYLATOXIN ACTIVITIES FROM THE THIRD AND FIFTH COMPONENTS OF HUMAN COMPLEMENT

H. Müller-Eberhard, C. Cochrane, Charles G. Cochrane, 1968, The Journal of experimental medicine.

Isolation and characterization of a noncytotoxic mast-cell activator from cobra venom

D. Morrison, P. Henson, J. Roser, 1975, Inflammation.

ACUTE IMMUNE COMPLEX DISEASE

P. Henson, C. Cochrane, 2003 .

Herman Beerman lecture. The participation of cells in the inflammatory injury of tissue.

C. Cochrane, 1975, The Journal of investigative dermatology.

Complement independent lipopolysaccharide (LPS) induced hypotension and disseminated intravascular coagulation: a correlation of LPS structure with in vivo and in vitro biological activities.

R. Ulevitch, D. Morrison, P. Henson, 1976, Advances in experimental medicine and biology.

Mediation systems in bacterial lipopolysaccharide-induced hypotension and disseminated intravascular coagulation. I. The role of complement

R. Ulevitch, D. Morrison, P. Henson, 1975, The Journal of experimental medicine.

Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.

J. Griffin, C. Cochrane, B. Bouma, 1977, Proceedings of the National Academy of Sciences of the United States of America.

Role of complement in lethal bacterial lipopolysaccharide-induced hypotensive and coagulative changes

R. Ulevitch, C. Cochrane, 1978, Infection and immunity.

Rabbit blood coagulation factor XI. Purification and properties.

J. Griffin, C. Cochrane, R. Wiggins, 1979, Thrombosis research.

Efficacy of Synthetic Peptide-Containing Surfactant in the Treatment of Respiratory Distress Syndrome in Preterm Infant Rhesus Monkeys

G. Heldt, C. Cochrane, T. Merritt, 1996, Pediatric Research.

Protein-phospholipid interactions in pulmonary surfactant. The Parker B. Francis Lectureship.

C. Cochrane, S. Revak, 1994, Chest.

The plasma contact system in atopic asthma.

J. Lang, C. Cochrane, J. Curd, 1983, The Journal of allergy and clinical immunology.

PLASMA PREKALLIKREIN: ISOLATION, CHARACTERIZATION, AND MECHANISM OF ACTIVATION

K. Wuepper, C. Cochrane, 1972, The Journal of experimental medicine.

ISOLATION AND CHARACTERIZATION OF PERMEABILITY FACTORS FROM RABBIT NEUTROPHILS

C. Cochrane, N. Ranadive, Pa D, 1968, The Journal of experimental medicine.

Activation of rat mast cells by low molecular weight stimuli.

D. Morrison, P. Henson, J. Roser, 1974, Journal of immunology.

Mechanism of histamine release from mast cells by cationic protein (band 2) from neutrophil lysosomes.

C. Cochrane, N. Ranadive, Charles G. Cochrane, 1971, Journal of immunology.

The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.

J. Griffin, C. Cochrane, S. Revak, 1977, The Journal of clinical investigation.

The enhancement of inflammatory injury.

C. Cochrane, 1987, The American review of respiratory disease.

Rabbit prekallikrein

R. Ulevitch, C. Cochrane, A. Johnston, 1980, Inflammation.

Positive End-Expiratory Pressure during KL4 Surfactant Instillation Enhances Intrapulmonary Distribution in a Simian Model of Respiratory Distress Syndrome

C. Cochrane, T. Merritt, A. Kheiter, 1995, Pediatric Research.

Hydrogen peroxide as a potent bacteriostatic antibiotic: implications for host defense.

D. Hinshaw, P. Hyslop, C. Cochrane, 1995, Free radical biology & medicine.

Structural Changes Accompanying Enzymatic Activation of

C. Cochrane, T. Hugli, A. Johnston, 2017 .

Biochemistry of Oxidant Injury

J. Jackson, O. Quehenberger, C. Cochrane, 1991 .

Recent Advances in The Understanding of Contact Activation Reactions

J. Griffin, C. Cochrane, 2008, Seminars in thrombosis and hemostasis.

Soluble mediators of injury of the microvasculature; Hageman factor and the kinin forming, intrinsic clotting and the fibrinolytic systems.

R. Ulevitch, D. Morrison, K. Wuepper, 1974, Microvascular research.

Monoclonal antibody NMS-1 increases N-formyl chemotactic peptide-mediated oxidative burst generation in human neutrophils.

A. Jesaitis, L. Sklar, V. von Tscharner, 1987, Journal of immunology.

IMMUNOLOGICAL INDUCTION OF INCREASED VASCULAR PERMEABILITY

P. Henson, C. Cochrane, 1969, The Journal of experimental medicine.

THE ROLE OF POLYMORPHONUCLEAR LEUKOCYTES IN THE INITIATION AND CESSATION OF THE ARTHUS VASCULITIS

C. Cochrane, F. Dixon, W. Weigle, 1959, The Journal of experimental medicine.

THE CUTANEOUS REACTION TO SOLUBLE ANTIGEN-ANTIBODY COMPLEXES

C. Cochrane, W. Weigle, 1958, The Journal of experimental medicine.

MECHANISMS INVOLVED IN THE DEPOSITION OF IMMUNE COMPLEXES IN TISSUES

C. Cochrane, 1971, The Journal of experimental medicine.

Bronchoalveolar Lavage with KL4-Surfactant in Models of Meconium Aspiration Syndrome

S. Andersson, H. Takamori, I. Schraufstätter, 1998, Pediatric Research.

Ascorbic Acid Enhances the Effects of 6-Hydroxydopamine and H 2 O 2 on Iron-dependent DNA Strand Breaks and Related Processes in the Neuroblastoma Cell

C. Cochrane, D. Niethammer, G. Bruchelt, 2006 .

Role of hydroxyl radical in DNA damage.

S. Weitzman, J. Jackson, R. Sauerheber, 1987, Transactions of the Association of American Physicians.

Molecular assembly in the contact phase of the Hageman factor system.

J. Griffin, C. Cochrane, 1979, The American journal of medicine.

The Contact (Hageman Factor) System in Inflammation

R. Wiggins, C. Cochrane, S. Revak, 1983 .

Alpha-1-proteinase inhibitor in inflammatory states of humans and laboratory animals.

C. Cochrane, 1988, The American journal of medicine.

The interaction of Hageman factor and immune complexes.

K. Wuepper, C. Cochrane, H. Spiegelberg, 1972, The Journal of clinical investigation.

Cell-dependent chemiluminescence. Modulation of the N-formyl chemotactic peptide (FNLPNTL) mediated oxidative burst in human polymorphonuclear leukocytes (PMNL) by murine monoclonal antibody NMS-1.

C. Cochrane, M. Schmitt, 1987, Free radical research communications.

Number of macrophages and distribution of mitotic activity in regressing and progressing Moloney sarcomas.

C. Cochrane, W. Doe, S. Russel, 1976, Journal of immunology.

Inflammatory cells in solid murine neoplasms. II. Cell types found throughout the course of moloney sarcoma regression or progression

S. Russell, G. Gillespie, C. Cochrane, 1976, International journal of cancer.

Studies on the pathogenesis of the adult respiratory distress syndrome.

R. Spragg, C. Cochrane, A. Cohen, 1982, The Journal of clinical investigation.

ISOLATION OF A FRAGMENT (C3a) OF THE THIRD COMPONENT OF HUMAN COMPLEMENT CONTAINING ANAPHYLATOXIN AND CHEMOTACTIC ACTIVITY AND DESCRIPTION OF AN ANAPHYLATOXIN INACTIVATOR OF HUMAN SERUM

H. Müller-Eberhard, C. Cochrane, V. Bokisch, 1969, The Journal of experimental medicine.

Hageman factor: Characterization and mechanism of activation

C. Cochrane, 1975 .

Structural changes accompanying enzymatic activation of human Hageman factor.

C. Cochrane, T. Hugli, A. Johnston, 1974, The Journal of clinical investigation.

The Chemistry and Biology of the Proteins of the Hageman Factor-Activated Pathways

R. Ulevitch, C. Cochrane, 1977 .

Effect of Plasma Kallikrein on Coagulation in Vitro 1

K. Wuepper, C. Cochrane, 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Reconstitution of surfactant activity using purified human apoprotein and phospholipids measured in vitro and in vivo.

C. Cochrane, M. Hallman, T. Merritt, 1986, The American review of respiratory disease.

In vivo, in vitro, and molecular aspects of interleukin-8 and the interleukin-8 receptors.

C. Cochrane, R. C. Hoch, I. Schraufstätter, 1996, The Journal of laboratory and clinical medicine.

The Use of Synthetic Peptides in the Formation of Biophysically and Biologically Active Pulmonary Surfactants

G. Heldt, R. Houghten, C. Cochrane, 1991, Pediatric Research.

Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity.

C. Cochrane, E. Degryse, M. Hallman, 1988, The Journal of clinical investigation.

The Arthus phenomenon--a mechanism of tissue damage.

C. Cochrane, 1967, Arthritis and rheumatism.

Transmembrane signalling by the N-formyl peptide receptor in stably transfected fibroblasts.

E. Prossnitz, R. Ye, O. Quehenberger, 1991, Biochemical and biophysical research communications.

Identification of an N-formyl peptide receptor ligand binding domain by a gain-of-function approach.

E. Prossnitz, R. Ye, O. Quehenberger, 1997, Biochemical and biophysical research communications.

Mediators of the arthus and related reactions.

C. Cochrane, 1967, Progress in allergy.

Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000.

A. Jesaitis, R. Allen, C. Cochrane, 1987, The Journal of clinical investigation.

Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis

R. Ulevitch, J. Lindstrom, V. Lennon, 1978, The Journal of experimental medicine.

POLYMORPHONUCLEAR LEUKOCYTES IN IMMUNOLOGIC REACTIONS

C. Cochrane, B. S. Aikin, Barbara S. Aikin, 2003 .

Anaphylactogenic properties of soluble antigen-antibody complexes in the guinea pig and rabbit.

C. Cochrane, F. Dixon, W. Weigle, 1960, Journal of immunology.

Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.

H. Müller-Eberhard, C. Cochrane, B. S. Aikin, 1970, Journal of immunology.

Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.

C. Cochrane, M. Ballow, Mark Ballow, 1969, Journal of immunology.

Further studies on the chemotactic factor of complement and its formation in vivo.

H. Müller-Eberhard, P. Ward, C. Cochrane, 1966, Immunology.

THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO

H. Müller-Eberhard, P. Ward, C. Cochrane, 1965, The Journal of experimental medicine.

The distribution of lipopolysaccharide in normocomplementemic and C3-depleted rabbits and rhesus monkeys.

R. Ulevitch, J. Mathison, J. Fletcher, 1980, The American journal of pathology.

Damage to the bases in DNA induced by stimulated human neutrophils.

J. Jackson, E. Gajewski, M. Dizdaroglu, 1989, The Journal of clinical investigation.

The effect of complement depletion on bacterial lipopolysaccharide (LPS)-induced hemodynamic and hematologic changes in the Rhesus monkey.

R. Ulevitch, J. Fletcher, C. Cochrane, 1978, The American journal of pathology.

Raman spectroscopic studies of model human pulmonary surfactant systems: phospholipid interactions with peptide paradigms for the surfactant protein SP-B.

I. W. Levin, C. Cochrane, J. Vincent, 1991, Biochemistry.

Intravascular release of intact cellular fibronectin during oxidant-induced injury of the in vitro perfused rabbit lung.

L. Sklar, M. Ginsberg, B. Bohl, 1986, The Journal of clinical investigation.

The cellular events associated with regression and progression of murine (moloney) sarcomas

S. Russell, C. Cochrane, 1974, International journal of cancer.

The Hageman Factor System: Mechanism of Contact Activation

J. Griffin, C. Cochrane, S. Revak, 1976 .

Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase.

L. Sklar, D. Hinshaw, R. Spragg, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Membrane‐cytoskeleton interactions and the regulation of chemotactic peptide‐induced activation of human granulocytes: The effects of dihydrocytochalasin B

A. Jesaitis, L. Sklar, C. Cochrane, 1985, Journal of cellular biochemistry.

Rapid modulation of N-formyl chemotactic peptide receptors on the surface of human granulocytes: formation of high-affinity ligand- receptor complexes in transient association with cytoskeleton

A. Jesaitis, L. Sklar, C. Cochrane, 1984, The Journal of cell biology.

Complement-dependent hemodynamic and hematologic changes in the rabbit

R. Ulevitch, C. Cochrane, 1977, Inflammation.

Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation.

C. Der, J. Jackson, J. Buss, 1990, Proceedings of the National Academy of Sciences of the United States of America.

The Role of Tyr and Lys of Interleukin-8 in the High Affinity Interaction with the Interleukin-8 Receptor Type A(*)

D. Barritt, C. Cochrane, Z. Oades, 1995, The Journal of Biological Chemistry.

The effect of complement depletion on neutrophil migration in acute immunologic arthritis.

P. Henson, C. Cochrane, M. McGrade, 1972, Journal of immunology.

Multiple sites on IL-8 responsible for binding to alpha and beta IL-8 receptors.

D. Barritt, C. Cochrane, Z. Oades, 1993, Journal of immunology.

Antibody Production by Transferred Cells1

C. Cochrane, F. Dixon, 1963 .

Immunologic tissue injury mediated by neutrophilic leukocytes.

C. Cochrane, Charles G. Cochrane, 1968, Advances in immunology.

DEPLETION OF RESERVE PROTEIN FROM EXTRAVASCULAR EXTRACELLULAR FLUID

G. Whipple, C. Cochrane, F. Lucas, 1959, The Journal of experimental medicine.

A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome.

M. Keszler, Brian Marcy, H. Desai, 2002, Pediatrics.

PLASMA PREKALLIKREIN: ISOLATION, CHARACTERIZATION, AND MECHANISM OF ACTIVATION

K. Wuepper, C. Cochrane, 1972, The Journal of experimental medicine.

The dynamics of ligand-receptor interactions. Real-time analyses of association, dissociation, and internalization of an N-formyl peptide and its receptors on the human neutrophil.

L A Sklar, A. Jesaitis, L. Sklar, 1984, The Journal of biological chemistry.

The relationship of structure and function in human Hageman factor. The association of enzymatic and binding activities with separate regions of the molecule.

C. Cochrane, S. Revak, 1976, The Journal of clinical investigation.

Plasma Kinin System: Proenzyme Components

K. Wuepper, C. Cochrane, E. Tucker, 1970, The Journal of Immunology.

Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma

J. Griffin, C. Cochrane, B N Bouma, 1978, The Journal of experimental medicine.

THE F IRST C OMPONENT OF THE K ININ-FORMING SYSTEM

K. Wuepper, C. Cochrane, In H Uman, 1971 .

In vitro activation of the contact (Hageman factor) system of plasma by heparin and chondroitin sulfate E.

K. Austen, R. Wiggins, Y. Hojima, 1984, Blood.

Pathogenesis of the Adult Respiratory Distress Syndrome

Charles G. Cochrane, R. Spragg, C. Cochrane, 1983 .

Rabbit blood coagulation factor XI. Mechanism of activation of rabbit Hageman factor (factor XII).

J. Griffin, C. Cochrane, R. Wiggins, 1979, Thrombosis research.

Pulmonary surfactant protein B (SP-B): structure-function relationships.

C. Cochrane, S. Revak, 1991, Science.

The kinetics of neutrophil activation. The response to chemotactic peptides depends upon whether ligand-receptor interaction is rate-limiting.

A. Jesaitis, L. Sklar, C. Cochrane, 1981, The Journal of biological chemistry.

The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome.

G. Heldt, C. Cochrane, A. Pramanik, 1996, American journal of respiratory and critical care medicine.

Human surfactant treatment of severe respiratory distress syndrome: pulmonary effluent indicators of lung inflammation.

D. Strayer, C. Cochrane, M. Hallman, 1986, The Journal of pediatrics.

Oxygen and Nitrogen Reactive Metabolites and Phagocytic Cells

M. Gimbrone, C. Cochrane, 2000 .

A COMPARISON WITH THE ARTHUS PHENOMENON*' 5' §

C. Cochrane, W. Weigle, 1958 .

Alterations in adenosine triphosphate and energy charge in cultured endothelial and P388D1 cells after oxidant injury.

D. Hinshaw, R. Spragg, P. Hyslop, 1985, The Journal of clinical investigation.

The participation of high molecular weight kininogen in hypotensive shock and intravascular coagulation.

C. Cochrane, S. Revak, 1980, Clinical immunology and immunopathology.

Absence of G(i) proteins in the Sf9 insect cell. Characterization of the uncoupled recombinant N-formyl peptide receptor.

E. Prossnitz, R. Ye, O. Quehenberger, 1992, The Journal of biological chemistry.

Cellular and molecular mechanisms of inflammation

M. Gimbrone, C. Cochrane, 1990 .

Mediators of the Arthus and Related Reactions (Part 2 of 2)

C. Cochrane, 1967 .

The initiation of mast cell degranulation: activation at the cell membrane.

D. Morrison, P. Henson, J. Roser, 1975, Journal of immunology.

GUINEA PIG BETA-1C-GLOBULIN: ITS RELATIONSHIP TO THE THIRD COMPONENT OF COMPLEMENT AND ITS ALTERATION FOLLOWING INTERACTION WITH IMMUNE COMPLEXES.

C. Cochrane, W. D. Linscott, Charles G. Cochrane, 1964, Journal of immunology.

Immunological induction of increased vascular permeability. II. Two mechanisms of histamine release from rabbit platelets involving complement.

P. Henson, C. Cochrane, 1969 .

The Initial Events in Leukocytic Stimulation

C. Cochrane, 1986 .

Ligand/receptor internalization: a spectroscopic analysis and a comparison of ligand binding, cellular response, and internalization by human neutrophils

L A Sklar, A. Jesaitis, L. Sklar, 1982, Journal of cellular biochemistry.

In vitro models for the study of oxidant-induced injury of cells in inflammation.

P. Hyslop, C. Cochrane, W. Halsey, 1988, Methods in enzymology.

Reconstitution of Human Surfactant Activity Using Low-Molecular-Weight Apoproteins

C. Cochrane, M. Hallman, T. Merritt, 1988 .

Leukocyte-induced tissue injury.

J. Jackson, C. Cochrane, 1988, Hematology/oncology clinics of North America.

Immune-complex-mediated biologic effects.

C. Cochrane, R. Wiggins, 1981, The New England journal of medicine.

Biochemical factors in pulmonary inflammatory disease.

R. Spragg, C. Cochrane, S. Revak, 1983, Chest.

Site of deposition of C3 in Arthus reactions of C4 deficient guinea pigs.

M. Frank, C. Cochrane, E. I. Green, 1973, Journal of immunology.

A clinical study of an unusual case of asthma associated with urticaria pigmentosa.

W. D. Mckee, R. Farr, C. Cochrane, 1966, The Journal of allergy.

The Contact System of Plasma: Biochemistry and Biology

C. Cochrane, 1981, Clinics in Immunology and Allergy.

The role of the third intracellular loop of the neutrophil N-formyl peptide receptor in G protein coupling.

E. Prossnitz, R. Ye, O. Quehenberger, 1993, The Biochemical journal.

Generation of bradykinin during incubation of hereditary angioedema plasma

H. Müller-Eberhard, C. Cochrane, C. Gerard, 1982 .

Polylysine domain of K-ras 4B protein is crucial for malignant transformation.

C. Der, J. Jackson, J. Buss, 1994, Proceedings of the National Academy of Sciences of the United States of America.

The fate of an N-formylated chemotactic peptide in stimulated human granulocytes. Subcellular fractionation studies.

A. Jesaitis, L. Sklar, C. Cochrane, 1983, The Journal of biological chemistry.

MACROPHAGES IN REGRESSING AND PROGRESSING MOLONEY SARCOMAS

S. Russell, C. Cochrane, W. Doe, 1976 .

Vascular adhesion molecules

M. Gimbrone, C. Cochrane, 1991 .

Human Surfactant Substitution in Severe Respiratory Distress Syndrome

C. Cochrane, L. Gluck, M. Hallman, 1984 .

Mediation of immunologic glomerular injury.

C. Cochrane, 1969, Transplantation proceedings.

Receptor-mediated endocytosis, host defense, and inflammation.

A. Jesaitis, C. Cochrane, 1983, Laboratory investigation; a journal of technical methods and pathology.

DIRECT EVIDENCE FOR HAGEMAN FACTOR (FACTOR XII) ACTIVATION BY BACTERIAL LIPOPOLYSACCHARIDES (ENDOTOXINS)

D. Morrison, C. Cochrane, 1974, The Journal of experimental medicine.

IMMUNOLOGICAL INDUCTION OF INCREASED VASCULAR PERMEABILITY

P. Henson, C. Cochrane, 1969, The Journal of experimental medicine.

Immunological I N D U C T I O N of Increased Vascular P E R M E a B I L I T Y Ii. Two M~.chanl'~s or Histm~!ce_ Release ~ro~ Rabbit Platelets Involving Com:plem:ent*

P. Henson, C. Cochrane, P. D., 2022 .

Structural changes accompanying enzymatic activation of human Hageman factor.

C. Cochrane, T. Hugli, A. Johnston, 1974, The Journal of clinical investigation.

Cellular mediators of immunological tissue injury.

P. Henson, C. Cochrane, 1970, Journal of the Reticuloendothelial Society.

Cellular injury by oxidants.

C. Cochrane, 1991, The American journal of medicine.

ACUTE IMMUNE COMPLEX DISEASE IN RABBITS

P. Henson, C. Cochrane, C. Cochrane, 1971, The Journal of experimental medicine.

POLYMORPHONUCLEAR LEUKOCYTES IN IMMUNOLOGIC REACTIONS

C. Cochrane, Barbara S. Aikin, 1966, The Journal of experimental medicine.

Sodium Dodecyl Sulfate ( SDS )-Acrylamide-Gd Electrophoresis

C. Cochrane, 2003 .

Factors Responsible for Decline of Inflammation in Arthus Hypersensitivity Vasculitis.†

C. Cochrane, F. Dixon, W. Weigle, 1959, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Basic proteins in rat neutrophils that increase vascular permeability.

C. Cochrane, N. Ranadive, 1970, Clinical and experimental immunology.